Cite
HARVARD Citation
Chakrabarti, S. et al. (2018). First Report of Dramatic Tumor Responses with Ramucirumab and Paclitaxel After Progression on Pembrolizumab in Two Cases of Metastatic Gastroesophageal Adenocarcinoma. Oncologist. pp. 840-843. [Online].